ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Global expression profile of enterohemorrhagic Escherichia coli O157:H7 in phagosome of murine macrophages.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 causes foodborne outbreaks leading to hemolytic uremic syndrome (HUS) via Shiga toxin (Stx). During HUS pathogenesis, EHEC O157:H7 is phagocytized by intestinal macrophages, although only a small proportion of internalized bacteria survive within the phagosome. To investigate this persistence, we performed global RNA-seq analysis of intracellular EHEC O157:H7 within murine macrophage phagosomes, complemented by in vitro assays simulating key phagosomal stressors. Our results reveal that EHEC employs a sophisticated survival strategy characterized by metabolic reprogramming and stress resistance. Inside macrophages, EHEC activates the SOS pathway, synthesizes membrane lipids, and engages NO detoxification mechanisms while repressing energetically costly virulence systems -motility, Type 3 Secretion System (T3SS), and Type 6 Secretion System (T6SS)-to prioritize survival. Notably, Shiga toxin gene regulation proved highly context-dependent: phagocytosis selectively upregulated the stx2a A subunit via the SOS response, whereas stx1a remained uninduced, likely restrained by NO-mediated repression. In contrast, under in vitro multi-stress conditions (pH 4.5) engaged the AR2-AR5 acid resistance systems and triggered robust expression of both stx1a subunits (A and B). These findings highlight the dynamic, stress-specific regulatory networks EHEC relies on to persist within the host.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.